Acute Mast Cell Leukemia Preceded by Malignant Mediastinal Germ Cell Tumor: A Case Report and Literature Review

References

• Peter Valent CA, Dean D. Metcalfe. Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood. 2017;129(11):1420–1427.
   PubMed Web of Science ®Google Scholar
• Pardanani A. Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management. Am J Hematol. 2019;94(3):363–377.
   PubMed Web of Science ®Google Scholar
• Georgin-Lavialle S, Lhermitte L, Dubreuil P, Chandesris MO, Hermine O, Damaj G. Mast cell leukemia. Blood. 2013;121(8):1285–1295.
   PubMed Web of Science ®Google Scholar
• Preetesh Jain SW, Patel KP, Sarwari N, Cortes J, Kantarjian H, Verstovsek S. Mast cell leukemia (MCL): clinico-pathologic and molecular features and survival outcome. Leuk Res. 2017;59:105–109.
   PubMed Web of Science ®Google Scholar
• Leguit R, Hebeda K, Kremer M, et al. The Spectrum of Aggressive Mastocytosis: a Workshop Report and Literature Review. Pathobiology. 2020;87(1):2–19.
   PubMed Web of Science ®Google Scholar
• Urbini M, Schepisi G, Bleve S, et al. Primary Mediastinal and Testicular Germ Cell Tumors in Adolescents and Adults: a Comparison of Genomic Alterations and Clinical Implications. Cancers. 2021;13:20.
   Web of Science ®Google Scholar
• Taylor J, Donoghue M, Ho C, et al. Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor. J Clin Invest. 2020;130(12):6668–6676.
   PubMed Web of Science ®Google Scholar
• Cheng L, Albers P, Berney D, et al. Testicular cancer. Nat Rev Dis Primers. 2018;4(1):29.
   PubMed Web of Science ®Google Scholar
• Hartmann J, Nichols C, Droz J, et al. Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors. J Natl Cancer Inst. 2000;92(1):54–61.
   PubMedGoogle Scholar
• Escribano L, Orfao A, Díaz-Agustin B, et al. Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications. Blood. 1998;91(8):2731–2736.
   PubMed Web of Science ®Google Scholar
• Valent P, Sotlar K, Sperr WR, et al. Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal. Ann Oncol. 2014;25(9):1691–1700.
   PubMed Web of Science ®Google Scholar
• Jawhar M, Schwaab J, Meggendorfer M, et al. The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm. Haematologica. 2017;102(6):1035–1043.
   PubMed Web of Science ®Google Scholar
• Terada K, Yamaguchi H, Ueki T, et al. Full-length mutation search of the TP53 gene in acute myeloid leukemia has increased significance as a prognostic factor. Ann Hematol. 2018;97(1):51–61.
   PubMed Web of Science ®Google Scholar
• Tsutsumi M, Miura H, Inagaki H, et al. An aggressive systemic mastocytosis preceded by ovarian dysgerminoma. BMC Cancer. 2020;20(1):1162.
   PubMed Web of Science ®Google Scholar
• Winkelmann N, Schäfer V, Rinke J, et al. Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies. J Cancer Res Clin Oncol. 2017;143(12):2511–2519.
   PubMed Web of Science ®Google Scholar
• Wakamatsu M, Okuno Y, Murakami N, et al. Detection of subclonal SETBP1 and JAK3 mutations in juvenile myelomonocytic leukemia using droplet digital PCR. Leukemia. 2021;35(1):259–263.
   PubMed Web of Science ®Google Scholar
• Poli R, Scatolini M, Grosso E, et al. Malignant struma ovarii: next-generation sequencing of six cases revealed Nras, Braf, and Jak3 mutations. Endocrine. 2021;71(1):216–224.
   PubMed Web of Science ®Google Scholar
• Lee KC. Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors. Cancer. 1994;73(5):1535–1536.
   PubMed Web of Science ®Google Scholar
• Sowithayasakul P, Sinlapamongkolkul P, Treetipsatit J, et al. Hematologic Malignancies Associated With Mediastinal Germ Cell Tumors: 10 Years’ Experience at Thailand’s National Pediatric Tertiary Referral Center. J Pediatr Hematol Oncol. 2018;40(6):450–455.
   PubMed Web of Science ®Google Scholar
• Vlasveld LT, Splinter TA, Hagemeijer A, Van Lom K, Löwenberg B. Acute myeloid leukaemia with +i(12p) shortly after treatment of mediastinal germ cell tumour. Br J Haematol. 1994;88(1):196–198.
   PubMed Web of Science ®Google Scholar
• Ladanyi M, Samaniego F, Reuter VE, et al. Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumors. J Natl Cancer Inst. 1990;82(3):221–227.
   PubMedGoogle Scholar
• Chaganti RS, Ladanyi M, Samaniego F, et al. Leukemic differentiation of a mediastinal germ cell tumor. Genes Chromosomes Cancer. 1989;1(1):83–87.
   PubMed Web of Science ®Google Scholar
• Nichols CR, Hoffman R, Einhorn LH, Williams SD, Wheeler LA, Garnick MB. Hematologic malignancies associated with primary mediastinal germ-cell tumors. Ann Intern Med. 1985;102(5):603–609.
   PubMed Web of Science ®Google Scholar
• Lu C, Riedell P, Miller CA, et al. A common founding clone with TP53 and PTEN mutations gives rise to a concurrent germ cell tumor and acute megakaryoblastic leukemia. Cold Spring Harbor Mol Case Studies. 2016;2(1):a000687.
   PubMedGoogle Scholar
• Leonard JT, Raess PW, Dunlap J, Hayes-Lattin B, Tyner JW, Traer E. Functional and genetic screening of acute myeloid leukemia associated with mediastinal germ cell tumor identifies MEK inhibitor as an active clinical agent. J Hematol Oncol. 2016;9:31.
   PubMed Web of Science ®Google Scholar
• Oshrine BR, Olsen MN, Heneghan M, et al. Acquired isochromosome 12p, somatic TP53 and PTEN mutations, and a germline ATM variant in an adolescent male with concurrent acute megakaryoblastic leukemia and mediastinal germ cell tumor. Cancer Genet. 2014;207(4):153–159.
   PubMed Web of Science ®Google Scholar
• Akizuki K, Sekine M, Kogure Y, et al. TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia. BMC Cancer. 2020;20(1):5.
   PubMed Web of Science ®Google Scholar
• Amra N, Zarate LV, Punia JN, et al. Mediastinal Germ Cell Tumor and Acute Megakaryoblastic Leukemia With Co-occurring KRAS Mutation and Complex Cytogenetics. Pediatric Dev Pathol. 2020;23(6):461–466.
   PubMed Web of Science ®Google Scholar
• Vaishampayan U, Dan ME, Hussain M. Unusual hematologic malignancies. Case 2. Mediastinal germ cell tumor, malignant histiocytosis, and acute leukemia. J Clin Oncol. 2002;20(17):3739–3742.
   PubMed Web of Science ®Google Scholar